February 2014

DoD Partners with Industry to Produce Own Bioterrorism Countermeasures

DoD Partners with Industry to Produce Own Bioterrorism Countermeasures

WASHINGTON — For the first time, DoD is partnering with an outside company to build a facility to manufacture countermeasures to fight bioterrorism and other medical threats.

Lawmakers ‘Shocked’ by Surgical Implant Vendor Role in Patient Care

Lawmakers ‘Shocked’ by Surgical Implant Vendor Role in Patient Care

By Sandra Basu WASHINGTON — Lawmakers expressed alarm at a government report that vendor representatives were involved directly in the application of skin grafts at a VA medical center and demanded more oversight of the use, tracking and procurement of… Read More

Greater Pharmacist Intervention Tested to Increase Anticoagulant Adherence Rates

Greater Pharmacist Intervention Tested to Increase Anticoagulant Adherence Rates

By Annette M. Boyle PALO ALTO, CA — Medication is only effective if taken, yet how to make sure patients maintain adherence with anticoagulants and many other long-term medications for chronic diseases poses one of the greatest dilemmas for healthcare… Read More

Controversy Surrounds FDA Approval of New Opioid Analgesic

SAN DIEGO — The Food and Drug Administration has approved a new opioid analgesic but not without controversy. In approving Zohydro ER (hydrocodone bitartrate extended-release capsules), the FDA went against an 11-2 recommendation by a panel of outside experts to… Read More

FDA Allows Marketing of First Device for Migraine Headache Pain

SUNNYVALE, CA — For the first time, the Food and Drug Administration is allowing marketing of a device to relieve pain caused by migraine headaches that are preceded by an aura. The device, the Cerena Transcranial Magnetic Stimulator (TMS), is… Read More

New SGLT2 Inhibitor Approved to Treat Type 2 Diabetes

WASHINGTON — A new sodium-glucose co-transporter 2 (SGLT2) inhibitor has been approved to treat type 2 diabetes. The Food and Drug Administration approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults. Farxiga is marketed… Read More

Unspecified Anxiety Disorder Diagnosis Significantly Decreases Treatment for Veterans

Unspecified Anxiety Disorder Diagnosis Significantly Decreases Treatment for Veterans

HOUSTON — About 40% of veterans with anxiety disorders receive a “placeholder” diagnosis that often remains with them indefinitely — and dramatically reduces the likelihood they ever will receive appropriate care, according to a new study.

How Prescribers Discuss Opioid Use/Abuse with Patients

INDIANAPOLIS — From press reports, it might seem that everyone is talking about opioid analgesics. The question that VA researchers set out to answer, however, is how prescribers were discussing use of the pain relievers with their patients. A pilot… Read More

Opioid Use Raises Depression Risk in Veterans

ST. LOUIS, MO — The chronic use of opioid analgesics is linked to an increase in the risk of developing major depression, according to a review of veterans’ medical records. The study, led by Saint Louis University researchers, was published… Read More

DNA Used to Predict Amputee’s Pain Levels

SAN FRANCISCO — Researchers now are able to predict which wounded servicemembers are likely to develop persistent, chronic pain after amputation based on variants in their individual DNA sequence. The report on the medical advancement, led by researchers from Duke… Read More